Evidence map›Paper›PMID 37556555›Full record

ArticleScience translational medicine2023

Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.

Joseph W Guarnieri, Joseph M Dybas, Hossein Fazelinia, Man S Kim, Justin Frere, Yuanchao Zhang, Yentli Soto Albrecht, Deborah G Murdock, Alessia Angelin, Larry N Singh and 41 more

Open access · hybridAbstract read
In one paragraph

Article in Science translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
26.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 170 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Palmitoylated COX-2Journal of advanced research · 2026
    Article
  18. Article
  19. Article
  20. Review

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors at 18 institutions in 7 countries.

Joseph W GuarnieriCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0001-7802-7826
Joseph M DybasChildren's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0001-6700-3378
Hossein FazeliniaChildren's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Man S KimCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-1507-9829
Justin FrereIcahn School of Medicine at Mount Sinai, New York, NY 10023, USA.ORCID 0000-0002-7514-8873
Yuanchao ZhangCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Yentli Soto AlbrechtCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-2121-3115
Deborah G MurdockCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0003-0843-2126
Alessia AngelinCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-7115-5451
Larry N SinghCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-2478-5864
Scott L WeissCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Sonja M BestCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0003-0206-297X
Marie T LottCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0003-2035-479X
Shiping ZhangCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-1996-5289
Henry CopeUniversity of Nottingham, Nottingham, UK.ORCID 0000-0002-4984-0567
Victoria ZaksasCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0001-7916-4902
Amanda Saravia-ButlerCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0001-7505-2743
Cem MeydanCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0002-0663-6216
Jonathan FooxWeill Cornell Medicine, New York, NY 10065, USA.
Christopher MozsaryWeill Cornell Medicine, New York, NY 10065, USA.
Yaron BramWeill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0001-9711-575X
Yared KidaneCOVID-19 International Research Team, Medford, MA 02155, USA .
Waldemar PriebeCOVID-19 International Research Team, Medford, MA 02155, USA .
Mark R EmmettCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0002-9248-5767
Robert MellerCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0003-3528-8019
Sam DemharterDKAbzu ApS, Copenhagen 2150, Denmark.ORCID 0000-0001-7352-3994
Valdemar Stentoft-HansenDKAbzu ApS, Copenhagen 2150, Denmark.ORCID 0000-0002-8541-7731
Marco SalvatoreDKAbzu ApS, Copenhagen 2150, Denmark.
Diego GaleanoCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0002-1748-7148
Francisco J EnguitaCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0002-8072-8557
Peter GrabhamCollege of Physicians and Surgeons, Columbia University, New York, NY 19103, USA.
Nidia S TrovaoCOVID-19 International Research Team, Medford, MA 02155, USA .
Urminder SinghCOVID-19 International Research Team, Medford, MA 02155, USA .
Jeffrey HaltomCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0003-4534-2920
Mark T HeiseUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Nathaniel J MoormanUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Victoria K BaxterUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Emily A MaddenUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0003-0209-914X
Sharon A Taft-BenzUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Elizabeth J AndersonUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0001-7877-1639
Wes A SandersUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Rebekah J DickmanderUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0002-5367-6587
Stephen B BaylinCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0003-3697-3798
Eve Syrkin WurteleCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0003-1552-9495
Pedro M Moraes-VieiraCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0002-8263-786X
Deanne TaylorCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-3302-4610
Christopher E MasonCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0002-1850-1642
Jonathan C SchislerCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0001-7382-2783
Robert E SchwartzCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0002-5417-5995
Afshin BeheshtiCOVID-19 International Research Team, Medford, MA 02155, USA .ORCID 0000-0003-4643-531X
Douglas C WallaceCenter for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.ORCID 0000-0002-7480-8278
Children's Hospital of Philadelphia · USUniversity of North Carolina at Chapel Hill · USCornell University · USCambridge Systematics (United States) · USDet Danske Sprog- og Litteraturselskab (Denmark) · DKIowa State University · USAmes Research Center · USBroad Institute · USColumbia University · USIcahn School of Medicine at Mount Sinai · USJohns Hopkins University · USNational Institutes of Health · USTexas Scottish Rite Hospital for Children · USThe University of Texas MD Anderson Cancer Center · USUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Chicago · USUniversity of Lisbon · PTUniversity of Nottingham · GB

Funding

Virus-Host Interactions: Induction and Evasion of Host Innate ImmunityZIAAI001125 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BEST, SONJA · 2010 to 2025
$28.1M
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyteR01DK121072 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHWARTZ, ROBERT E · 2020 to 2024
$2.6M
Mechanisms of immunopathology of COVID-19/ARDS, and strategies to mitigate detrimental inflammatory responsesZIAAI001292 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BEST, SONJA · 2020 to 2025
$2.4M
Pathogenesis of and host response to chikungunya virus infection of the central nervous systemK01OD026529 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BAXTER, VICTORIA K · 2018 to 2022
$631k
NIH HHS K01 OD026529
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral proteins bind to host mitochondrial proteins, likely inhibiting oxidative phosphorylation (OXPHOS) and stimulating glycolysis. We analyzed mitochondrial gene expression in nasopharyngeal and autopsy tissues from patients with coronavirus disease 2019 (COVID-19). In nasopharyngeal samples with declining viral titers, the virus blocked the transcription of a subset of nuclear DNA (nDNA)-encoded mitochondrial OXPHOS genes, induced the expression of microRNA 2392, activated HIF-1α to induce glycolysis, and activated host immune defenses including the integrated stress response. In autopsy tissues from patients with COVID-19, SARS-CoV-2 was no longer present, and mitochondrial gene transcription had recovered in the lungs. However, nDNA mitochondrial gene expression remained suppressed in autopsy tissue from the heart and, to a lesser extent, kidney, and liver, whereas mitochondrial DNA transcription was induced and host-immune defense pathways were activated. During early SARS-CoV-2 infection of hamsters with peak lung viral load, mitochondrial gene expression in the lung was minimally perturbed but was down-regulated in the cerebellum and up-regulated in the striatum even though no SARS-CoV-2 was detected in the brain. During the mid-phase SARS-CoV-2 infection of mice, mitochondrial gene expression was starting to recover in mouse lungs. These data suggest that when the viral titer first peaks, there is a systemic host response followed by viral suppression of mitochondrial gene transcription and induction of glycolysis leading to the deployment of antiviral immune defenses. Even when the virus was cleared and lung mitochondrial function had recovered, mitochondrial function in the heart, kidney, liver, and lymph nodes remained impaired, potentially leading to severe COVID-19 pathology.

Indexed as

COVID-19AnimalsCricetinaeGenes, MitochondrialHumansLungMiceRodentiaSARS-CoV-2

Identifiers

PMID37556555
PMCPMC11624572
OpenAlexW4385693324

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.